FIELD: medicine. SUBSTANCE: composition has cytostatic agent and TNF-α. Preparations intercollating into DNA is taken as the cytostatic agent and biologically active mouramylpeptide is added. Mass proportions of the cytostatic agent, muramylpeptide and TNF -α is 1:0.06 - 300:0.00001 - 0.1. EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES SHOWING REGENERATIVE-REPARATIVE ACTION | 1994 |
|
RU2065445C1 |
| SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
| METHOD OF PREPARING RECOMBINANT THYMIDINE PHOSPHORYLASE, RECOMBINANT PLASMID DNA PERTPHO1 AND STRAIN ESCHERICHIA COLI BL21(DE3)/PERTPHO1 AS PRODUCER OF THYMIDINE PHOSPHORYLASE | 2000 |
|
RU2188234C2 |
| METHOD OF ISOLATION OF GENOME DNA FROM MICROORGANISM CELLS | 2000 |
|
RU2185440C2 |
| STRAIN OF HYBRID CULTIVATED ANIMAL CELLS Mus musculus A 6G2-PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC TO HEAT SHOCK PROTEIN 70 | 2008 |
|
RU2380413C1 |
| METHOD FOR PREPARING QUICK ACTION INSULIN SOLUTION FOR MAKING INJECTIONS | 2001 |
|
RU2202365C2 |
| GENETICALLY MODIFIED MOUSE FIBROBLAST LINE NIH/3T3-174 | 2007 |
|
RU2396343C2 |
| METHOD OF PREPARING A CARBOHYDRATE-PROTEIN COMPLEX FROM JAPANESE SCALLOP | 1996 |
|
RU2121844C1 |
| PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
| RECOMBINANT PLASMID DNA PLP-3-1 ENCODING HUMAN POLYPEPTIDE OF PROINSULIN LYSPRO AND STRAIN OF BACTERIUM ESCHERICHIA COLI PLP-3-1/TG-1 AS PRODUCER OF RECOMBINANT PROINSULIN LYSPRO | 2003 |
|
RU2235776C1 |
